DaVita HealthCare Partners Inc (DVA)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 794,933 | 380,063 | 244,086 | 461,900 | 324,958 |
| Short-term investments | US$ in thousands | 135,788 | 56,111 | 184,708 | 79,135 | 72,395 |
| Total current liabilities | US$ in thousands | 2,973,410 | 2,642,210 | 2,619,750 | 2,398,530 | 2,476,140 |
| Cash ratio | 0.31 | 0.17 | 0.16 | 0.23 | 0.16 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($794,933K
+ $135,788K)
÷ $2,973,410K
= 0.31
The cash ratio of DaVita HealthCare Partners Inc has shown some fluctuations over the past five years. As of December 31, 2020, the company's cash ratio was 0.16, indicating that for every dollar of current liabilities, DaVita had $0.16 in cash and cash equivalents available to cover those obligations.
By December 31, 2021, the cash ratio had improved to 0.23, suggesting an increase in the company's ability to cover its short-term liabilities with its available cash reserves. However, this improvement was not sustained as the ratio dropped back to 0.16 by December 31, 2022.
In the following years, the cash ratio showed some stability with minor fluctuations. As of December 31, 2023, the cash ratio stood at 0.17, and by December 31, 2024, it had increased to 0.31. This indicates that DaVita HealthCare Partners Inc had notably strengthened its liquidity position by the end of 2024, with $0.31 in cash available for every dollar of current liabilities.
Overall, the analysis of the cash ratio for DaVita HealthCare Partners Inc suggests that the company made efforts to enhance its ability to meet short-term obligations with cash on hand, especially evidenced by the significant improvement in the cash ratio towards the end of the period under review.
Peer comparison
Dec 31, 2024